Published by Josh White on 29th November 2021
(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced on Monday that it has signed a two-year collaboration agreement with Imperial College London.
URL: http://www.digitallook.com/dl/news/story/32294847/...